Literature DB >> 28588718

Renal cell carcinoma with synchronous ipsilateral urothelial carcinoma of the renal pelvis.

Qun Lu1, Junlong Zhuang1, Hongqian Guo1.   

Abstract

The simultaneous occurrence of renal cell carcinoma (RCC) and urothelial carcinoma (UC) in the same kidney is extraordinarily rare, and is also known as multiple primary malignant tumors. The present study reports the case of a 76-year-old female with synchronous ipsilateral RCC and UC of the renal pelvis, who underwent operation, chemotherapy and reoperation when recurrence of RCC or UC was identified. Cluster of differentiation 44 (CD44) is one of the promising markers for identifying cancer stem cells in various solid tumors, along with aldehyde dehydrogenase 1 A1 (ALDH1A1). Detection of CD44 and ALDH1A1 prior to and subsequent to chemotherapy could provide useful prognostic information. New treatments against the cancer stem cells fraction should be used in combination with chemotherapy to improve the outcome for patients with overexpression of CSC markers.

Entities:  

Keywords:  ALDH1A1; CD44; renal cell carcinoma; synchronous; urothelial carcinoma

Year:  2017        PMID： 28588718      PMCID： PMC5452923          DOI： 10.3892/ol.2017.5981

Source DB:  PubMed          Journal:  Oncol Lett        ISSN： 1792-1074            Impact factor:   2.967


  18 in total

1.  Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.

Authors:  Shuji Mikami; Ryuichi Mizuno; Takeo Kosaka; Hideyuki Saya; Mototsugu Oya; Yasunori Okada
Journal:  Int J Cancer       Date:  2014-09-17       Impact factor: 7.396

Review 2.  Diagnosis and management of upper tract urothelial carcinoma.

Authors:  L M Krabbe; A Bagrodia; M E Westerman; V Margulis
Journal:  Minerva Urol Nefrol       Date:  2014-03       Impact factor: 3.720

3.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Authors:  Chad J Creighton; Xiaoxian Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael T Lewis; Jeffrey M Rosen; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

4.  ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.

Authors:  Hossein Keymoosi; Elmira Gheytanchi; Mojgan Asgari; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 5.  Cancer stem cells in bladder cancer: a revisited and evolving concept.

Authors:  Keith Syson Chan; Jens-Peter Volkmer; Irving Weissman
Journal:  Curr Opin Urol       Date:  2010-09       Impact factor: 2.309

Review 6.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

7.  Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.

Authors:  Alessandro Antonelli; Alberto Cozzoli; Maria Nicolai; Danilo Zani; Tiziano Zanotelli; Laura Perucchini; Sergio Cosciani Cunico; Claudio Simeone
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

8.  Multiple primary malignancies in renal cell carcinoma.

Authors:  F Rabbani; G Grimaldi; P Russo
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

9.  Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.

Authors:  Kosuke Ueda; Sachiko Ogasawara; Jun Akiba; Masamichi Nakayama; Keita Todoroki; Keiko Ueda; Sakiko Sanada; Shigetaka Suekane; Masanori Noguchi; Kei Matsuoka; Hirohisa Yano
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

10.  Renal cell carcinoma of the kidney with synchronous ipsilateral transitional cell carcinoma of the renal pelvis.

Authors:  Dogan Atilgan; Nihat Uluocak; Bekir Suha Parlaktas
Journal:  Case Rep Urol       Date:  2013-06-13
View more
  4 in total

1.  Synchronous ipsilateral renal cell carcinoma and transitional cell carcinoma of the renal pelvic with complete remission of TCC after neoadjuvant chemotherapy.

Authors:  Ali Safadi; Ibrahim Elias; Alexander Visoki; Anat Zick; Sergio Schwalb; Ran Katz
Journal:  Urol Case Rep       Date:  2018-05-04

2.  Two Different Upper Tract Urological Malignancies on Either Side.

Authors:  W S L De Silva; S R De Almeida; G D B J Karunarathne; A A S Samarathunga; K M C S Gannoruwa; J A S B Jayasundara
Journal:  Case Rep Urol       Date:  2021-09-21

Review 3.  More than meets the eye: A case of synchronous ipsilateral clear cell renal cell carcinoma and urothelial carcinoma of the pelvicalyceal system and literature review.

Authors:  Asterios Symeonidis; Ioannis Tsikopoulos; Evangelos N Symeonidis; Ioannis Tsifountoudis; Antonios Michailidis; Ioanna Tsantila; Chrysovalantis Gkekas; Christos Georgiadis; Apostolos Malioris; Michail Papathanasiou
Journal:  Acta Biomed       Date:  2022-01-19

4.  Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases.

Authors:  Nienie Qi; Yue Chen; Kan Gong; Hailong Li
Journal:  World J Surg Oncol       Date:  2018-01-25       Impact factor: 2.754
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.